← Back to contracts

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

US National Institutes of Health (NIH) - National Institute on Drug Abuse (NIDA) grant open #RFA-DA-26-055
Response due Dec 03, 2027 · 00:00 UTC

Summary

This NIH/NIDA funding opportunity (RFA-DA-26-055) invites R01 research grant applications focused on accelerating substance use research by leveraging existing data sources. Clinical trials are explicitly not allowed under this mechanism. The opportunity is broadly open from December 2024 through December 2027, suggesting a multi-cycle solicitation window for investigator-initiated research proposals.

What they want

Applicants must propose secondary research using existing data to advance the pace of substance use research. Clinical trials are not permitted. Research must align with NIDA's mission on substance use, addiction, and related topics. Proposals must follow the R01 grant mechanism requirements as defined by NIH.
Technical requirements
  • Must use existing data (no new data collection implied)
  • Clinical trials not allowed
  • R01 grant mechanism required
  • Must align with NIDA substance use research mission

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

  • No dollar value or budget cap stated — award size is unknown
  • Multi-year open window (3 years) may indicate rolling submission cycles with undisclosed review priorities

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Accelerating the Pace of Substance Use Res…
Due Dec 03
Onboard ↗